podcast
Patients/ Podcast/ Video/ Views & Analysis/ Views and analysis
Patient engagement strategies: the pharmaphorum podcast
Dominic Tyer
Mark Duman, MSD, patient engagement, podcast
0 Comment
Podcast/ Sales and Marketing/ Video/ Views & Analysis/ Views and analysis
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast
Dominic Tyer
BMS, Catherine Owen, commercialisation, comms, communications, podcast
0 Comment
Digital/ Podcast/ Video/ Views & Analysis/ Views and analysis
Virtual engagement and collaborations: the pharmaphorum podcast
Dominic Tyer
HCP engagement, impetus, Impetus Digital, podcast, virtual pharma meetings, vitual conferences
0 Comment
Podcast/ Sales and Marketing/ Video/ Views & Analysis/ Views and analysis
Vertex’s Nicola Massey: the pharmaphorum podcast
Podcast/ R&D/ Video/ Views & Analysis/ Views and analysis
Organicell on regenerative medicine: the pharmaphorum podcast
Dominic Tyer
COVID-19, Dr Maria Ines Mitrani, Organicell Regenerative Medicine, podcast, Regenerative medicine
0 Comment
Podcast/ R&D/ Video/ Views & Analysis/ Views and analysis
Pharmacy and clinical research: the pharmaphorum podcast
Dominic Tyer
clinical trials, decentralised trials, pharmacy, podcast, RxE2, virtual trials
0 Comment
Podcast/ Sales and Marketing/ Video/ Views & Analysis/ Views and analysis
Pharma’s post-COVID prospects: the pharmaphorum podcast
Dominic Tyer
Accenture, Pharma Sales, podcast, sales
0 Comment
Market Access/ Podcast/ Video/ Views & Analysis/ Views and analysis
Galapagos UK’s Michael Smyth on RNA-based tech: the pharmaphorum podcast
mike.smith@pharmaphorum.com
Galapagos, HTA, Michael Smyth, podcast, rna
0 Comment